Sartorius Stedim Biotech SA banner

Sartorius Stedim Biotech SA
PAR:DIM

Watchlist Manager
Sartorius Stedim Biotech SA Logo
Sartorius Stedim Biotech SA
PAR:DIM
Watchlist
Price: 166.8 EUR 0.57% Market Closed
Market Cap: €16.2B

Balance Sheet

Balance Sheet Decomposition
Sartorius Stedim Biotech SA

Balance Sheet
Sartorius Stedim Biotech SA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024 Dec-2025
Assets
Cash & Cash Equivalents
3
2
4
5
2
7
13
55
30
47
28
36
19
32
35
33
24
28
60
224
107
117
679
426
Cash Equivalents
3
2
4
5
2
7
13
55
30
47
28
36
19
32
35
33
24
28
60
224
107
117
679
426
Short-Term Investments
0
1
0
0
0
0
0
0
0
0
7
7
7
8
8
13
19
19
11
14
26
17
12
24
Total Receivables
10
8
17
19
16
90
78
74
86
96
99
115
134
152
205
236
233
232
263
371
419
334
300
224
Accounts Receivables
8
7
13
18
15
85
74
70
83
92
92
107
125
142
184
212
220
221
257
356
405
294
266
193
Other Receivables
2
1
4
1
1
5
4
3
3
3
7
8
9
10
21
24
13
11
6
15
14
40
34
32
Inventory
7
8
11
12
14
54
61
47
51
66
85
95
110
147
171
186
252
329
471
783
1 025
882
685
691
Other Current Assets
0
0
0
3
2
10
11
10
10
11
7
8
7
12
13
24
24
28
69
65
95
66
66
76
Total Current Assets
20
19
32
38
35
162
163
186
176
220
226
261
276
351
432
491
553
636
874
1 456
1 671
1 415
1 741
1 441
PP&E Net
19
20
23
21
20
114
114
112
113
132
160
176
192
223
261
331
436
550
644
928
1 292
1 633
1 885
2 025
PP&E Gross
19
20
23
21
20
114
114
112
113
132
160
176
192
223
261
331
436
550
644
928
1 292
1 633
1 885
2 025
Accumulated Depreciation
13
15
19
23
25
80
88
91
103
116
121
133
145
161
180
199
211
253
299
368
441
542
655
753
Intangible Assets
0
0
30
33
29
105
113
107
102
99
109
116
113
143
144
173
177
208
572
684
877
1 736
1 632
1 537
Goodwill
0
0
11
12
7
249
250
250
250
255
288
309
314
337
345
386
385
418
725
821
1 136
2 852
2 908
2 884
Note Receivable
0
0
0
0
0
0
2
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
1
0
0
2
2
2
2
3
1
1
1
1
2
12
6
14
13
15
25
41
24
19
Other Long-Term Assets
1
1
0
0
0
9
8
10
12
12
9
10
11
11
12
11
15
18
28
47
64
63
67
79
Other Assets
0
0
11
12
7
249
250
250
250
255
288
309
314
337
345
386
385
418
725
821
1 136
2 852
2 908
2 884
Total Assets
41
N/A
40
-2%
97
+140%
105
+9%
91
-13%
641
+603%
652
+2%
668
+2%
656
-2%
721
+10%
794
+10%
873
+10%
907
+4%
1 066
+18%
1 196
+12%
1 404
+17%
1 571
+12%
1 845
+17%
2 857
+55%
3 951
+38%
5 065
+28%
7 740
+53%
8 256
+7%
7 984
-3%
Liabilities
Accounts Payable
6
4
14
12
9
31
32
29
35
44
40
52
49
61
68
77
104
117
175
251
252
259
310
278
Accrued Liabilities
3
3
7
9
10
0
0
0
0
0
24
15
22
26
29
32
39
41
60
97
74
62
88
99
Short-Term Debt
4
4
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
9
7
4
156
32
38
40
43
106
28
73
89
76
98
92
55
24
40
24
79
65
581
Other Current Liabilities
1
1
1
2
1
35
34
53
70
82
61
63
85
96
111
144
148
216
309
648
686
537
476
455
Total Current Liabilities
13
11
32
30
26
222
98
120
145
168
230
158
230
273
284
350
382
428
568
1 037
1 036
937
939
1 412
Long-Term Debt
0
0
26
24
14
5
131
104
92
104
36
137
33
30
26
62
58
84
563
585
1 112
3 603
2 805
2 019
Deferred Income Tax
0
0
9
9
8
36
37
35
34
30
30
34
28
30
29
43
39
45
85
126
178
400
358
376
Minority Interest
0
0
0
0
0
0
2
0
0
2
3
3
7
6
6
7
8
30
23
77
65
35
37
36
Other Liabilities
0
0
0
0
0
14
15
16
20
23
63
63
78
87
93
69
47
99
180
470
225
127
131
52
Total Liabilities
13
N/A
11
-15%
67
+485%
64
-4%
48
-25%
278
+476%
283
+2%
275
-3%
291
+6%
327
+12%
362
+11%
395
+9%
375
-5%
425
+13%
438
+3%
532
+21%
535
+1%
687
+28%
1 419
+107%
2 295
+62%
2 616
+14%
5 102
+95%
4 270
-16%
3 893
-9%
Equity
Common Stock
3
4
4
4
4
10
10
10
10
10
10
10
15
15
18
18
18
18
18
18
18
18
20
20
Retained Earnings
21
22
24
35
36
352
359
383
355
384
427
478
515
603
722
844
1 010
1 131
1 441
1 617
2 411
2 622
3 920
4 127
Additional Paid In Capital
3
3
2
2
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Equity
0
0
0
0
0
0
0
0
0
0
5
10
3
23
18
9
8
9
21
20
20
3
47
56
Total Equity
27
N/A
29
+5%
30
+4%
41
+37%
43
+4%
363
+746%
370
+2%
393
+6%
365
-7%
394
+8%
432
+10%
478
+11%
532
+11%
641
+20%
758
+18%
872
+15%
1 036
+19%
1 159
+12%
1 438
+24%
1 656
+15%
2 449
+48%
2 638
+8%
3 987
+51%
4 091
+3%
Total Liabilities & Equity
41
N/A
40
-2%
97
+140%
105
+9%
91
-13%
641
+603%
652
+2%
668
+2%
656
-2%
721
+10%
794
+10%
873
+10%
907
+4%
1 066
+18%
1 196
+12%
1 404
+17%
1 571
+12%
1 845
+17%
2 857
+55%
3 951
+38%
5 065
+28%
7 740
+53%
8 256
+7%
7 984
-3%
Shares Outstanding
Common Shares Outstanding
38
42
42
42
42
101
102
102
92
92
92
92
92
92
92
92
92
92
92
92
92
92
97
97
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett